Hantz Financial Services Inc. Has $2.36 Million Holdings in Sanofi (NASDAQ:SNY)

Hantz Financial Services Inc. trimmed its holdings in Sanofi (NASDAQ:SNY) by 2.1% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 48,904 shares of the company’s stock after selling 1,055 shares during the quarter. Hantz Financial Services Inc.’s holdings in Sanofi were worth $2,359,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds have also added to or reduced their stakes in the company. Stablepoint Partners LLC increased its position in shares of Sanofi by 0.8% during the third quarter. Stablepoint Partners LLC now owns 23,893 shares of the company’s stock worth $1,377,000 after acquiring an additional 189 shares in the last quarter. PDS Planning Inc lifted its position in shares of Sanofi by 3.1% during the third quarter. PDS Planning Inc now owns 6,643 shares of the company’s stock valued at $383,000 after purchasing an additional 200 shares in the last quarter. Eagle Ridge Investment Management boosted its holdings in Sanofi by 3.8% during the third quarter. Eagle Ridge Investment Management now owns 5,571 shares of the company’s stock worth $321,000 after purchasing an additional 203 shares during the last quarter. Financial Advocates Investment Management grew its position in Sanofi by 3.4% in the 3rd quarter. Financial Advocates Investment Management now owns 6,327 shares of the company’s stock worth $365,000 after purchasing an additional 206 shares in the last quarter. Finally, Angeles Investment Advisors LLC increased its stake in Sanofi by 1.9% in the 3rd quarter. Angeles Investment Advisors LLC now owns 11,323 shares of the company’s stock valued at $653,000 after buying an additional 210 shares during the last quarter. 14.04% of the stock is currently owned by institutional investors.

Sanofi Stock Performance

Shares of SNY opened at $54.15 on Friday. The stock’s fifty day moving average price is $49.12 and its two-hundred day moving average price is $52.24. Sanofi has a 1 year low of $45.22 and a 1 year high of $58.97. The firm has a market cap of $137.42 billion, a PE ratio of 27.63, a PEG ratio of 1.19 and a beta of 0.57. The company has a debt-to-equity ratio of 0.17, a current ratio of 1.00 and a quick ratio of 0.65.

Sanofi (NASDAQ:SNY) last posted its earnings results on Thursday, January 30th. The company reported $0.70 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.70. Sanofi had a return on equity of 27.45% and a net margin of 9.96%. On average, equities research analysts forecast that Sanofi will post 3.82 EPS for the current year.

Wall Street Analyst Weigh In

A number of brokerages recently commented on SNY. Deutsche Bank Aktiengesellschaft raised Sanofi from a “sell” rating to a “hold” rating in a research report on Thursday. StockNews.com cut Sanofi from a “buy” rating to a “hold” rating in a research note on Thursday, December 12th. Two investment analysts have rated the stock with a hold rating, one has issued a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, Sanofi has a consensus rating of “Moderate Buy” and a consensus price target of $60.00.

About Sanofi

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, Canada, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products.